157 related articles for article (PubMed ID: 37741955)
1. Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells.
Li MY; Zhang J; Lu X; Zhou D; Deng XF; Liu QX; Dai JG; Zheng H
Cancer Chemother Pharmacol; 2024 Jan; 93(1):41-54. PubMed ID: 37741955
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S
J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer.
Dou Q; Chen HN; Wang K; Yuan K; Lei Y; Li K; Lan J; Chen Y; Huang Z; Xie N; Zhang L; Xiang R; Nice EC; Wei Y; Huang C
Cancer Res; 2016 Aug; 76(15):4457-69. PubMed ID: 27302166
[TBL] [Abstract][Full Text] [Related]
5. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
[TBL] [Abstract][Full Text] [Related]
7. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
8. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
Jin R; Wang X; Zang R; Liu C; Zheng S; Li H; Sun N; He J
Cancer Lett; 2020 Jul; 483():46-58. PubMed ID: 32272148
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
Chung JH; Kim DH; Kim YS; Son BS; Kim D; Hwang C; Shin D; Noh SG; Han JH; Kim DK; Kim JH; Koo JS; Chung HY; Yoon SH
Cell Physiol Biochem; 2018; 50(1):304-316. PubMed ID: 30282071
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
11. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer.
Wang K; Gao W; Dou Q; Chen H; Li Q; Nice EC; Huang C
Autophagy; 2016 Dec; 12(12):2498-2499. PubMed ID: 27657889
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
15. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
[TBL] [Abstract][Full Text] [Related]
16. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
17. STK11 mutation affects the killing effect of NK cells to promote the progression of lung adenocarcinoma.
Huang Y; Zhang H; Feng J; Tang B
APMIS; 2022 Nov; 130(11):647-656. PubMed ID: 35988018
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
Sun X; Wang R; Tan M; Tian X; Meng J
Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
[TBL] [Abstract][Full Text] [Related]
19. CWHM-1008 Induces Apoptosis and Protective Autophagy through the Akt/mTOR Axis in LUAD Cells.
Zhang J; Li MY; Lu X; Liu QX; Zhou D; Yang GX; Liu XQ; Zheng H; Dai JG
J Oncol; 2021; 2021():5548128. PubMed ID: 35096055
[TBL] [Abstract][Full Text] [Related]
20. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
Liu Z; Hu Z; Cai X; Liu S
Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]